Skip to Main Content

Paper Details

Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies.
Eur Neuropsychopharmacol
48
2018
AMPS, CYP2C19, CYP2C19 functional polymorphisms, Cytochrome (CYP) P450 enzymes, PMs, citalopram, cytochrome CYP2C19, escitalopram, patients, polymorphic genes, polymorphisms, rs12248560, rs4244285
Author NameAffiliation
Roy H PerlisCenter for Experimental Drugs and Diagnostics, Massachusetts General Hospital
Roy H PerlisCenter for Experimental Drugs and Diagnostics, Massachusetts General Hospital
Joanna HauserPoznan University of Medical Sciences
Wolfgang MaierUniversity of Bonn
Ole MorsAarhus University Hospital
Marcella RietschelCentral Institute of Mental Health
Gerome BreenInstitute of Psychiatry, King's College London
Gerome BreenInstitute of Psychiatry, King's College London
Charles CurtisInstitute of Psychiatry, King's College London
Sang-Hyuk LeeInstitute of Psychiatry, King's College London
Stephen J NewhouseInstitute of Psychiatry, King's College London
Hamel PatelInstitute of Psychiatry, King's College London
Michael C O'DonovanInstitute of Psychological Medicine and Clinical Neurosciences, Cardiff University
Gregory D JenkinsMayo Clinic
Richard M WeinshilboumMayo Clinic
Anne FarmerInstitute of Psychiatry, King's College London
Peter McGuffinInstitute of Psychiatry, King's College London
Joanna M BiernackaMayo Clinic
  • 1 - 18

Datasets